Evidence map›Paper›PMID 37956043›Full record

ArticleeLife2023

Molecular portraits of colorectal cancer morphological regions.

Eva Budinská, Martina Hrivňáková, Tina Catela Ivkovic, Marie Madrzyk, Rudolf Nenutil, Beatrix Bencsiková, Dagmar Al Tukmachi, Michaela Ručková, Lenka Zdražilová Dubská, Ondřej Slabý and 5 more

Abstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Piezo channels in tumors.Journal of cancer research and clinical oncology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular pathological classification of colorectal cancer-an update.Virchows Archiv : an international journal of pathology · 2024
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Eva BudinskáRECETOX, Faculty of Science, Masarykova Univerzita, Brno, Czech Republic.
Martina HrivňákováRECETOX, Faculty of Science, Masarykova Univerzita, Brno, Czech Republic.
Tina Catela IvkovicCentral European Institute of Technology, Masarykova Univerzita, Brno, Czech Republic.
Marie MadrzykCentral European Institute of Technology, Masarykova Univerzita, Brno, Czech Republic.
Rudolf NenutilMasaryk Memorial Cancer Institute, Brno, Czech Republic.
Beatrix BencsikováMasaryk Memorial Cancer Institute, Brno, Czech Republic.
Dagmar Al TukmachiCentral European Institute of Technology, Masarykova Univerzita, Brno, Czech Republic.
Michaela RučkováCentral European Institute of Technology, Masarykova Univerzita, Brno, Czech Republic.
Lenka Zdražilová DubskáFaculty of Medicine, Masarykova Univerzita, Brno, Czech Republic.
Ondřej SlabýCentral European Institute of Technology, Department of Biology, Faculty of Medicine, Masarykova Univerzita, Brno, Czech Republic.
Josef FeitDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Masarykova Univerzita, Brno, Czech Republic.
Mihnea-Paul DragomirInstitute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Petra Borilova LinhartovaRECETOX, Faculty of Science, Masarykova Univerzita, Brno, Czech Republic.
Sabine TejparFaculty of Medicine, Digestive Oncology Unit, Katholieke Universiteit Leuven, Leuven, Belgium.
Vlad PopoviciRECETOX, Faculty of Science, Masarykova Univerzita, Brno, Czech Republic.ORCID 0000-0002-1311-9188

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterogeneity of colorectal carcinoma (CRC) represents a major hurdle towards personalized medicine. Efforts based on whole tumor profiling demonstrated that the CRC molecular subtypes were associated with specific tumor morphological patterns representing tumor subregions. We hypothesize that whole-tumor molecular descriptors depend on the morphological heterogeneity with significant impact on current molecular predictors. We investigated intra-tumor heterogeneity by morphology-guided transcriptomics to better understand the links between gene expression and tumor morphology represented by six morphological patterns (morphotypes): complex tubular, desmoplastic, mucinous, papillary, serrated, and solid/trabecular. Whole-transcriptome profiling by microarrays of 202 tumor regions (morphotypes, tumor-adjacent normal tissue, supportive stroma, and matched whole tumors) from 111 stage II-IV CRCs identified morphotype-specific gene expression profiles and molecular programs and differences in their cellular buildup. The proportion of cell types (fibroblasts, epithelial and immune cells) and differentiation of epithelial cells were the main drivers of the observed disparities with activation of EMT and TNF-α signaling in contrast to MYC and E2F targets signaling, defining major gradients of changes at molecular level. Several gene expression-based (including single-cell) classifiers, prognostic and predictive signatures were examined to study their behavior across morphotypes. Most exhibited important morphotype-dependent variability within same tumor sections, with regional predictions often contradicting the whole-tumor classification. The results show that morphotype-based tumor sampling allows the detection of molecular features that would otherwise be distilled in whole tumor profile, while maintaining histopathology context for their interpretation. This represents a practical approach at improving the reproducibility of expression profiling and, by consequence, of gene-based classifiers.

Indexed as

Colorectal NeoplasmsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansReproducibility of ResultsTranscriptomecancer biologycolorectal cancerhumanintra-tumor heterogeneitymorphologytranscriptomics

Identifiers

PMID37956043
PMCPMC10642970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.